Medicine

A five-judge panel in Brazil unanimously ruled in favor of three patients’ rights to grow their own cannabis for medical purposes.

A new poll found that 91% of adults who have consumed cannabis have done so for health and/or wellness purposes.

Kansas Gov. Laura Kelly (D) has signed a bill allowing state residents to consume FDA-approved drugs derived from cannabis.

Matthew X. Lowe, Ph.D., is the Research Director for Realm of Caring — a cannabis non-profit focused on increasing access to cannabis medicine — and Research Director for Unlimited Sciences, a psychedelics research non-profit.

Police arrested activists outside of the headquarters of the DEA as they protested the agency’s refusal to let terminally ill patients access experimental drugs like psilocybin and MDMA.

Consuming cannabis flower has been shown to improve symptoms of fatigue in 91% of study participants, according to new research by the University of New Mexico.

South Carolina’s Legislature declared its latest medical cannabis bill unconstitutional over a tax provision, defeating the bill for this year.

Legalizing adult-use cannabis lowers the demand for prescription drugs through state Medicaid programs, according to a recent study.

The Arizona Court of Appeals ruled that a mother enrolled in the state’s medical cannabis program per a doctor’s recommendation cannot be charged with neglect if their newborn baby tests positive for cannabis.

South Dakota started approving medical cannabis patient and physician applications but at a rate that could make it difficult for patients to connect with doctors registered for the program.

Cyo Nystrom is the CEO and co-founder of Quim, a THC and CBD self-care line for humans with vaginas and people who love them.

Lolita Korneagay is the nurse-turned-entrepreneur behind Cansoom, which offers cannabis-focused continuing education for medical professionals and more.

Two companies have accused the DEA of delaying the application process for bulk cannabis manufacturing in the production of cannabinoid-based pharmaceuticals.

Terminally ill patients in California are now allowed to receive medical cannabis treatments while in the hospital under a new law starting this year.

A new survey found 88.8% of patients with a skin condition would try a medical cannabis-based treatment.

Medical cannabis company Cannabit-Tikun Olam is partnering with pharmaceutical firm Teva Israel to produce cannabis products for international distribution.

Pfizer is making its move into the cannabis space with the acquisition of Arena Pharmaceuticals, Inc. in a $6 billion, all-cash deal.

A recent study found that the incidence of epileptic seizures in children decreased an average of 86% when treated with whole-plant cannabis.

A recent survey found 65% of patients were able to reduce or eliminate taking at least one prescription medication after obtaining their medical cannabis registration.

Pennsylvania-based research firm Affinity Bio Partners is investigating the potential efficacy of cannabis for diabetic nerve pain.

Colombia’s President Ivan Duque last week signed a decree lifting the ban on dried cannabis flower exports and expanding the sale of medical cannabis products.

Trulieve GA Inc. and Biomedical Sciences LLC were awarded the two Class 1 licenses to produce low-THC medical cannabis oil for Georgia’s medical cannabis program.

Police in Cork, Ireland have removed six cannabis plants that were placed outside of the City Hall by a pro-cannabis activist to draw attention to a cannabis patient who moved to Spain for access to medical cannabis.